颅内多发胶质瘤的发病机制及临床诊断进展  

The pathogenesis and clinical progress of multiple cerebral gliomas

作　　者：陈胜利[1] 杜靖宇 胡昌辰[1] 齐泽迪 陈良崇 CHEN Shengli;DU Jingyu;HU Changchen;QI Zedi;CHEN Liangchong(Department of Neurosurgery,Shanxi Provincial People’s Hospital,Taiyuan,Shanxi 030012,China;Shanxi Medical University,Taiyuan,Shanxi 030001,China)

机构地区：[1]山西省人民医院神经外科,山西省太原市030012 [2]山西医科大学,山西省太原市030001

出　　处：《中南医学科学杂志》2022年第3期319-322,共4页Medical Science Journal of Central South China

基　　金：国家自然科学基金(30901774);山西省人民医院省级专项配套经费科研项目(sj20019003)。

摘　　要：多发胶质瘤(MCG)是一类相当棘手的疾病,对其进行有效切除及控制是神经外科最具挑战的临床工作之一。MCG的确切发病机制目前尚不明确,治疗上尚无成熟的临床路径。本文根据MCG相关临床研究文献,从MCG的发病机制、临床诊断、鉴别诊断等方面进行了综述,以期为MCG高效治疗手段的研发提供参考。Multiple cerebral glioma(MCG)is a very tricky disease,and effective radical treatment of it is extremely challenging in oncology.The exact pathogenesis of MCG is currently unclear,and there is still no universal approach.Based on the main clinical research literature related to MCG,in order to provide reference for the development of efficient treatment of MCG,this article reviews the pathogenesis,clinical diagnosis,differential diagnosis of MCG.

关 键 词：颅内多发胶质瘤 发病机制 临床诊断 鉴别诊断 

分 类 号：R739.41[医药卫生—肿瘤]